Sodium hyaluronate solutions have been advocated in the management of a variety of dry-eye states. By virtue of their non-Newtonian rheological properties, for mulations exhibiting high zero-shear viscosities may be used as an artificial tear with the expectation of prolonged precorneal residence times and improved tolerance.
Although a variety of therapeutic strategies can be utilised in the management of dry-eye disorders,1.2 the basis of therapy remains the artificial tear. The principal limitation of currently available tear substitutes is the short duration of symptom control experienced by some patients. A number of approaches have, therefore, been adopted to prolong the time they remain in contact with the ocular surface including the use of high viscosity formula tions,"· slow-release artificial tears' and occlusion of the lacrimal puncta.1> However, none of these methods have met with uniform success.
Polymer solutions formulated at high vis cosity have longer residence times, 7 .H but are poorly tolerated because of transmitted 'University of Oxford, Department of Ophthalmology.
shearing forces associated with blinking and rapid eye movements. It is in this respect that formulations of polymers that display non Newtonian or pseudoplastic properties offer a potential therapeutic advantage over conven tional artificial tears. At concentrations of 0. 2% and 0.3% , sodium hyaluronate solu tions exhibit high static. or zero-shear, vis cosities but undergo dramatic reduction in viscosity with increasing shear rate� ( Fig. 1) , thereby offering significantly less resistance to the movement of the lid over the globe than viscous Newtonian formulations. It is the expectation of prolonged residence time asso ciated with high zero-shear viscosities, and of patient acceptance owing to its shear-thinning behaviour, that has lead to the investigation of sodium hyaluronate solutions as potential tear substitutes. Few studies have addressed the relation ship between the acceptability of viscous eye drops to human subjects and their rheological properties. Methylcellulose and polyvinyl alcohol solutions, which are essentially New tonian, have been reported to produce dis comfort at viscosities of 30 cPo 10 Dudinski et al. evaluated a range of polymers of dif fering rheology and although unable directly to correlate rheology with acceptability, of those tested, the polymer exhibiting greatest pseudoplasticity was preferred by most sub jects to more Newtonian solutions.
I I
Several clinical trials have now reported efficacy of sodium hyaluronate solutions in the treatment of Keratoconjunctivitis sicca and other dry-eye conditions. ' 2 .]J,'� .' 5 .' 6 . '7.' K Solutions of 0.1 % sodium hyaluronate have also been shown to prolong tear film break-up time ' H.u.!9 but few attempts have been made to quantify the precorneal residence times of these formulations in man.
A variety of methods have been devised to quantify residence time. Staining of the con junctival and corneal epithelium with an Argyrol marker was used by Bach et al. in 1972,x and the results obtained indicated that hydroxypropylmethylcellulose (HPMC) had a longer contact time than polyvinyl alcohol. It was concluded that the differences related to the differing viscosities of the polymer solu tions. Adler, Maurice and Peterson, in 1971,] Lacrimal gamma scintigraphy, a technique first described by Rossomondo et al. in 197224 to evaluate lacrimal drainage, has been used with some modifications in both rabbits2 5 .2 6 and mann.2x to study preocular residence times of drug delivery vehicles. In this study, quantitative gamma scintigraphy was employed to measure the precorneal and ocular surface residence times of two concen trations of sodium hyaluronate and a buffered saline solution in patients with well docu mented keratoconjunctivitis sicca and in a group of normal volunteers. A method of laser interferometry was also used in an attempt to correlate the effect of these for mulations on tear film thickness with resi dence times.
Method
Nine females and three males with keratocon junctivitis sicca or Sjogren's syndrome, aged between 37 and 75 (mean 59 years), were recruited from the External Disease Clinic in Oxford. Each patient was required to have at least two symptoms attributable to dry eyes necessitating regular artificial tear therapy in addition to abnormal values for at least two of the accepted clinical tests of tear film ade quacy: Schirmer's test values of less than 5.5 mm in five minutes and tear film break-up times, using a non-invasive method,29 of less than ten seconds were regarded as abnormal.
Rose bengal stammg of the interpalpebral region of the ocular surface was graded on a scale of 0-5 for the cornea and each of the medial and lateral bulbar conjunctival areas and an aggregate score of six or more was determined to be abnormal. None of the patients gave a history of other external disease or anterior segment surgery, nor were they currently using any form of topical medi cation other than artificial tears. A group of six normal volunteers, without external disease and of a similar age and sex distri bution, also participated in the study. Each subject was given a verbal and written explanation of the procedure and their informed consent was obtained.
Three formulations were studied: 0.2% and 0. 3% sodium hyaluronate (SH) in a buffered saline solution and the buffered saline itself (BS). Each subject was randomly allocated to receive the three formulations in one of six possible orders and studies were performed a minimum of five days apart to eliminate any possibility of interaction or residual activity. The isotope used was technetium 99m che lated with diethylenetriaminepentaacetic acid (DTPA), a commonly employed radiophar maceutical, in a sterile saline solution. A small volume (0.10-0.40 m!) of each formula tion was replaced with the isotope prep aration, the exact volume depending on the activity of the 99Tcm eluted from the generator at the time of the study. The mean dilution was 4% and was similar for the three for-mulations studied. Sufficient tracer was added to give each 25 f.A.! drop an activity of approxi mately one megaBecquerel (MBq). The resultant activity of the individual drop was calculated from the measured activity of 5.0 ml of the labelled formulation immedi ately prior to commencement of each study. The mean activity was 1.0 MBq (range 0.81-1.55) without significant differences between the three formulations. The reliability and accuracy of these steps were confirmed in sep arate experiments in which multiple samples were taken from a range of labelled solutions and counts obtained from each sample with the gamma camera under experimental conditions. Subjects were seated with their he�d sup ported so that the eye to be studied was 5.0 cm from the 3. 5 mm aperture of the pinhole col limator of the IGE 400T gamma camera. A 25 f..l l drop was placed on the superior aspect of the globe using a Transferpettor direct dis placement pipette and the subject was encour aged to maintain a normal blink rate with both eyes open and in the primary position. Acqui sition was commenced simultaneously and continued without interruption for 36 min utes. In order to detect early and rapid changes, time frames of two seconds were used for the first two minutes increasing in length to 60 second frames for the last 15 min utes. Images were stored on magnetic disc and processed by a Picker pes 512 minicomputer and later copied to optical disc for permanent storage.
At the conclusion of each study, the field of view of the gamma camera was divided into five regions of interest (ROI) on the basis of previously determined anatomical landmarks and the distribution of activity seen when the image of the totalised study is displayed on the monitor. One large rectangle was used to encompass the entire ocular surface excluding the region of the inner canthus. A smaller rectangle was used to represent the corneal surface excluding activity associated with the tear meniscus and any possible contamination of the lashes or lid margin. The medial canthal area and the lacrimal sac were described by a third region and a fourth outlined the naso lacrimal duct. A small peripheral area was used to record background gamma radiation (Fig. 2) .
In a separate experiment, the effect of each formulation on tear film thickness was studied dynamically in a normal volunteer using a technique based on laser interferometry. Baseline measurements were made prior to instillation of a 10 fl.l drop and interference fringes were recorded and measurements made until tear film thickness returned to baseline. Each solution was studied three times on separate days. A detailed account of the method used is reported elsewhere. 30
Results
Counts were obtained from each region of interest and for each of the 183 time frames. From these counts, after correction for back ground values, curves were generated expres sing the percentage activity remaining as a function of time for each of the regions of interest (Fig. 3) . Curve-fitting was performed using the programme MINIM for the Apple Macintosh computer. In this way rates of clearance of the isotope from the cornea and ocular surface could be compared for each test solution in each of the 18 subjects (Fig. 4) . Due to excessive movement during the study of one normal subject, curve-fitting was not possible and these data were excluded from further analysis. From individual curve-fit plots for the dry eye patients, the time taken for half of the for mulation (reflected by the detected gamma emission from the 99 Tcffi) to be cleared from the ocular surface (T5o) was derived for each solution. Student's paired t-test was used to evaluate differences between mean Tso values for the three formulations studied. The 0.3% solution of sodium hyaluronate cleared significantly more slowly than the buffered saline solution (p<O.OOl). The 0.2% solution also remained on the ocular surface much longer than the polymer-free preparation (p = 0.003). The more viscous 0.3% solution cleared more slowly than 0.2% sodium hya luronate and this difference was also signifi cant (p = 0.033). Similarly, cIearance of �he sodium hyaluronate solutions from the central corneal surface was also retardeq compared with the buffered saline. Corres ponding increases in activity recorded from the areas of the lacrimal sac and nasolacrimal duct were much smaller and slower for the more viscous formulations.
Although mean T 5 0 values for the normal subjects followed the same trend, there was considerable variation between subjects and the differences did not attain statistical signifi cance. Mean T 5 0 values for the hyaluronate solutions were approximately half those found in dry eye patients (Fig. 5) .
The function which gave closest approxi mation to the clearance curves in most cases was the following biexponential equation: y = A*exp(-kjt)+B*exp(-k2t). This pro vides constants, kj and k2, which allow com parisons between solutions for different phases of the curves. Using analysis of vari ance, significant differences between mean values for both kl and k2 for the three for mulations were demonstrated for the ocular surface curves. This was the case in both normal subjects and those with dry eyes
The area under the curves provides another index of residence time and the differences between mean areas for the ocular surface region were also significant in favour of the more viscous formulations (between BS and 0.2% SH, P = 0.006; between BS and 0.3% SH, p<O.OOl).
The volume of the solution remaining at the end of the study provides some indication of its long term persistence. By comparing counts obtained from the 35th minute of acq � isition, after correction for initial activity, sodIUm hyaluronate would appear to persist � n the ocular surface in much greater quanti tieS than the polymer-free buffered saline.
Tear film thickness, in all cases, increased after instillation of the drop and reached a maximum value within a few seconds. Maxi mum thickness was noted, as was the time taken for the tear film to return to its baseline thickness (Fig. 6 ). There appears to be a clear tre � d with greater thickening produced by the sodiUm hyaluronate solutions; the difference between the thickening effects of the buffered saline and 0.2% sodium hyaluronate being statistically significant (p = 0.026). Although recovery time would also appear to be vis cosity-related, further experiments are necessary to confirm this.
Discussion
A variety of properties have been regarded as important in the formulation of tear substi tutes including viscosity, surface tension ton icity, pH, and the ability to simulat� the properties of tear film mucus. Clinical trials to date have failed to give preeminence to any one of these factors and the search for the ideal artificial tear continues. A feature of the tear film attributed to ocular surface mucus3l is the psuedoplastic property of shear rate dependent viscosity, a property shared by sodium hyaluronate in solution by virtue of its high molecular weight and flexible, open-coil conformation.Y The possible advantage of an artificial tear possessing these characteristics is the opportunity to use high viscosity for mulations with prolongation of precorneal residence time and tear film stability. To our knowledge, the residence times of sodium hyaluronate solutions in dry eye patients have not previously been studied.
Quantitative gamma scintigraphy is a safe and effective non-invasive means of evaluat ing the preocular residence times of ophthal mic preparations.3 2 Using this method we were able to demonstrate, in dry-eye patients, a mean ocular surface residence time for O.?% SH, as reflected by the mean Tso, of 23.5 mmutes (1,407 sec). For 0.2% SH the mean Tso was 11.1 minutes (665 sec) compared with less than one minute (50 sec) for the buffered saline solution. Despite marked variation in rate of clearance between subjects all these d�ff � rences attained statistical significance. Similar trends were observed for the region corresponding to the corneal surface. As would be anticipated, the appearance of the tracer in the lacrimal sac and nasolacrimal duct was delayed and slower for the viscous preparations. Delayed drainage would be expected to enhance the persistence of the polymer in the tear film meniscus which could act as a reservoir serving to replenish the pre ocular tear/polymer film with each blink.
Although early clearance kinetics are of interest, only a small proportion of the instilled volume is likely to be necessary to provide stability to the tear film. An indica tion of the longer term persistence of small quantities of polymer is given by the second phase of the biexponential curve described by the constant k 2 . Differences were also demon strated on the basis of k 2 in favour of the more viscous formulations. Similarly, by comparing areas under clearance curves and corrected counts obtained from the penultimate frames (35th minute), greater persistence of the 0. 3% and 0.2% sodium hyaluronate can be demonstrated. At least in the case of sodium hyaluronate solutions, these findings would support the statement that residence time is viscosity-related, a concept that has been challenged in the past. 10 . These data also com pare favourably with the residence times of polyvinyl alcohol, hydroxypropylmethylcel lulose 2 8 and hydroxyethylcellulose33 that have been determined using similar scintigraphic methods.
The shorter residence times of sodium hya luronate which we have demonstrated in normal subjects, compared with patients with KCS, would caution against comparing resi dence times determined in these different populations and suggest that it is more appro priate to study residence times of artificial tears in individuals with dry eyes. This differ ence might be explained solely by the dilu tional and wash-out effects of reflex and basal lacrimation which are diminished in KCS; but squamous metaplasia, which is evident to some extent in severely dry eyes,34 may also play a role in altering adhesion of the polymer or increasing the resistance to canalicular out flow. Alternatively, an alteration of tear mucin or of surface epithelial glycocalyx in dry eyes might modify the interaction with sodium hyaluronate and explain the differ ences in group behaviour. The rate of clear ance of the buffered saline was similar for both groups of subjects and we were unable to confirm the findings of Weber et al. 3 5 who demonstrated hyperexcretion in a subgroup of dry-eye patients. Viscosity alone may to a large extent explain the prolonged residence times of sodium hyaluronate solutions, but adhesion or physical attachment to the ocular surface has been suggested by some 12 ,36 and has been recently demonstrated using an in vitro experimental model. 37 Although the presence of binding sites for sodium hyaluronate has been demonstrated on the surface of the cor neal endothelium, none has been found on the epithelial surface. 38 Scanning and trans mISSIon electron microscopy has been employed by Hazlett and Barrett3 9 to demon strate the persistence of sodium hyaluronate for at least 60 minutes on the corneal surface of mice that would appear not to be depend ent on the presence of an intact mucus layer. This would suggest an interaction between the polymer and either the glycocalyx or the cell membranes of the epithelial surface.
Thickening of the precorneal tear film by viscous polymer solutions has been demon strated previously using a fluorophotometric method;4 0 however, the duration of this effect has not been quantified. Using a non-invasive method, we were able to demonstrate thick ening of the tear film after instillation of all three test formulations. The magnitude of this effect appears to be viscosity-related; and, for the hyaluronate solutions, the recovery time is approximately twice the ocular surface T 5 0 value.
One mechanism by which this thickening might occur is by increasing the volume of the marginal tear meniscus. It is also likely that a large. hydrophilic molecule adsorbed at the corneal surface would be capable' of stabilise ing to some extent the aqueous phase into 'which it projects. A third mechanism, sug gested and supported experimentally b y B�n edetto, Shah and Kaufman,4 0 is that a film of polymer adsorbed at the air/tear interface is able to support a layer of water beneath it which is dragged in over the ocular surface and each blink.
The clinical value of sodium hyaluronate solutions in the management of patients with dry eyes has yet to be determined conclu sively. The design and conduct of sound clini cal trials of artificial tears are not without difficulty, owing to the paucity of reliable objective parameters for assessing change. These studies must als o be of sufficient power to account for the therapeutic effect of the saline placebo. Some (unpublished) random ised controlled trials have failed to demon strate a clear benefit over placebo. However, Nelson and Fari"is have shown 0.1% sodium hyaluronate to be at least as effective as 1.4% polyvinyl alcohol18 and Sand, Marner and Norn have recently reported a placebo-con trolled trial with differences in rose bengal staining, tear film break-up time and patient preference in favour of a 0.2% sodium hyalu ronate preparation. 41 A number of uncon trolled clinical trials in selected patients have also reported efficacy. 12 , 1 3 , 14 The properties of artificial tear formula tions that are most important in the enhance ment of tear film thickness and stability remain, to a large extent, unknown. How ever, in the light of some encouraging clinical data, the prolonged residence times of sodium hyaluronate solutions together with their favourable rheological properties, would sug gest that their further evaluation as a tear sub stitute may provide a useful new agent in the management of dry-eye states.
